Cannabis legalisation in Canada: a crucial trial balloon

Lancet Psychiatry. 2019 Jan;6(1):5-6. doi: 10.1016/S2215-0366(18)30460-7.

Authors

Kevin P Hill¹, Tony P George²

Affiliations

¹ Division of Addiction Psychiatry, Harvard Medical School, Boston, MA, USA; Beth Israel Deaconess Medical Center, Boston, MA 02215, USA. Electronic address: khill1@bidmc.harvard.edu.
² Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Addictions Division, Centre for Addiction and Mental Health, Toronto, ON, Canada.

PMID: 30579495
DOI: 10.1016/S2215-0366(18)30460-7

No abstract available

Publication types

Editorial

MeSH terms

Canada
Cannabis*
Humans
Legislation, Drug*